Plenary Session 6 presentation title: “Inhibiting complement activation in IgAN”
Dana Rizk MD
Professor of Medicine, Nephrology Division, University of Alabama at Birmingham
Dr Dana Rizk is Professor of Medicine in the Division of Nephrology at the University of Alabama at Birmingham (UAB).
Her clinical and research interests revolve around glomerular diseases and, in particular IgA Nephropathy. She has served as the site principal investigator on many clinical trials and is part of several multi-disciplinary translational research projects focused on the role of biomarkers in IgAN.
She has more than 45 peer-reviewed publications in prestigious medical journals including the New England Journal of Medicine.
Dr Rizk has been the Director of Clinical Trials Research in the Division of Nephrology since 2015 and also serves as the Medical Director for the Clinical Trials Administrative Office at UAB.